Literature DB >> 19119758

Oncology consent forms: failure to disclose off-site treatment availability.

David B Resnik1, Shyamal Peddada, Jason Altilio, Nancy Wang, Jerry Menikoff.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 19119758      PMCID: PMC2791355     

Source DB:  PubMed          Journal:  IRB        ISSN: 0193-7758


× No keyword cloud information.
  10 in total

1.  High-dose chemotherapy plus autologous bone marrow transplantation for metastatic breast cancer.

Authors:  M E Lippman
Journal:  N Engl J Med       Date:  2000-04-13       Impact factor: 91.245

2.  What makes clinical research ethical?

Authors:  E J Emanuel; D Wendler; C Grady
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

3.  FDA, off-label use, and informed consent: debunking myths and misconceptions.

Authors:  J M Beck; E D Azari
Journal:  Food Drug Law J       Date:  1998       Impact factor: 0.619

4.  Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patients.

Authors:  C K Daugherty; D M Banik; L Janish; M J Ratain
Journal:  IRB       Date:  2000 May-Jun

5.  Patient or guinea pig? Dilemma of clinical trials.

Authors:  Denise Grady
Journal:  N Y Times Web       Date:  1999-01-05

6.  Clinical trial registration: a statement from the International Committee of Medical Journal Editors.

Authors:  Catherine De Angelis; Jeffrey M Drazen; Frank A Frizelle; Charlotte Haug; John Hoey; Richard Horton; Sheldon Kotzin; Christine Laine; Ana Marusic; A John P M Overbeke; Torben V Schroeder; Hal C Sox; Martin B Van Der Weyden
Journal:  N Engl J Med       Date:  2004-09-08       Impact factor: 91.245

7.  Off-label use of medicines: consensus recommendations for evaluating appropriateness.

Authors:  Madlen Gazarian; Maria Kelly; John R McPhee; Linda V Graudins; Robyn L Ward; Terence J Campbell
Journal:  Med J Aust       Date:  2006-11-20       Impact factor: 7.738

8.  Open clinical trials.

Authors:  Jeffrey M Drazen; Stephen Morrissey; Gregory D Curfman
Journal:  N Engl J Med       Date:  2007-10-03       Impact factor: 91.245

9.  New uses for old drugs.

Authors:  Curtis R Chong; David J Sullivan
Journal:  Nature       Date:  2007-08-09       Impact factor: 49.962

Review 10.  Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review.

Authors:  Jeffrey M Peppercorn; Jane C Weeks; E Francis Cook; Steven Joffe
Journal:  Lancet       Date:  2004-01-24       Impact factor: 79.321

  10 in total
  3 in total

1.  Assent Described: Exploring Perspectives From the Inside.

Authors:  Rebecca D Poston
Journal:  J Pediatr Nurs       Date:  2016-07-09       Impact factor: 2.145

2.  Evaluating the quality of information about alternatives to research participation in oncology consent forms.

Authors:  David B Resnik; Daniel Patrone; Shyamal Peddada
Journal:  Contemp Clin Trials       Date:  2009-11-06       Impact factor: 2.226

3.  Which alternatives should investigators disclose to research subjects?

Authors:  John Phillips; David Wendler
Journal:  Am J Bioeth       Date:  2014       Impact factor: 11.229

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.